Crossmark

Synthetic free fatty acid receptor (FFAR) 2 agonist 4-CMTB and FFAR4 agonist GSK13764 inhibit colon cancer cell growth and migration and regulate FFARs expression in in vitro and in vivo models of colorectal cancer

Crossref DOI link: https://doi.org/10.1007/s43440-024-00667-5

Published Online: 2024-10-21

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Binienda, Agata https://orcid.org/0000-0002-1173-2966
Owczarek, Katarzyna https://orcid.org/0000-0002-1351-2406
Sałaga, Maciej https://orcid.org/0000-0002-5917-8749
Fichna, Jakub https://orcid.org/0000-0002-8443-4417
Funding

Funding for this research was provided by:

Ministerstwo Edukacji i Nauki (0229/DIA/ 2019/48)

Uniwersytet Medyczny w Lodzi (503/1-156-04/503-11-001-19)
License Information

Text and Data Mining valid from 2024-10-21

Version of Record valid from 2024-10-21
More Information

Article History

Received: 16 July 2024

Revised: 10 October 2024

Accepted: 12 October 2024

First Online: 21 October 2024

Declarations

:

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below